Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-02
2007-01-02
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S363000, C514S384000, C514S415000, C514S444000, C546S193000, C548S262600, C548S136000, C548S469000, C549S059000
Reexamination Certificate
active
10429461
ABSTRACT:
The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula I:or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
REFERENCES:
patent: 5032602 (1991-07-01), Fey et al.
patent: 5998447 (1999-12-01), Stilz et al.
patent: 6710058 (2004-03-01), Jacobson et al.
patent: 2005/0096309 (2005-05-01), Han et al.
patent: 0 454 444 (1991-10-01), None
patent: 0 522 606 (1993-01-01), None
patent: 0 908 764 (1999-04-01), None
patent: WO 95/14012 (1995-05-01), None
patent: WO 97/36900 (1997-10-01), None
patent: WO 99/31506 (1999-06-01), None
patent: WO 99/31507 (1999-06-01), None
patent: WO 99/32477 (1999-07-01), None
patent: WO 99/42455 (1999-08-01), None
patent: WO 00/69826 (2000-11-01), None
patent: WO 00/69832 (2000-11-01), None
patent: WO 00/69833 (2000-11-01), None
patent: WO 00/69834 (2000-11-01), None
patent: WO 03/053925 (2003-07-01), None
McMurry, John “Organic Chemistry—Fourth Edition” Brooks/Cole Publishing Company, 1996, p. 694.
Han Wei
Hu Zilun
Pinto Donald J.
Qiao Jennifer X.
Smallheer Joanne M.
Kosack Joseph R.
Saeed Kamal A.
Sun Jing G.
Vance David H.
LandOfFree
Sulfonylaminovalerolactams and derivatives thereof as factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonylaminovalerolactams and derivatives thereof as factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonylaminovalerolactams and derivatives thereof as factor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3724577